Hot Medical Stocks To Buy For 2019

Portola Pharmaceuticals (NASDAQ:PTLA) could win approvals from the Food and Drug Administration for two important new drugs in the coming year. Its drug betrixaban could become the first of a new class of drugs to be green-lighted for reducing the chance of blood clots forming in acute medically ill patients, and its AndexXa could become the first antidote approved to reverse the effects of top-selling anticoagulants that are already billion-dollar blockbusters.

In this clip from The Motley Fool’s Industry Focus: Healthcarepodcast, analyst Kristine Harjes and contributor Todd Campbell discuss the opportunity ahead for this biotech, and what’s next on deck for investors.

A transcript follows the video.

This podcast was recorded on March 6, 2017.

Kristine Harjes:We havearrived at our lastcompany of the day, which is also this year’sbiggest winner so far, up72%. This is a name that Todd and Italk about a lot. We both really like this company. That isPortola Pharmaceuticals.

Hot Medical Stocks To Buy For 2019: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Rofin-Sinar Technologies (NASDAQ: RSTI) got a boost, shooting up 37 percent to $31.50 as Coherent, Inc. (NASDAQ: COHR) announced its plans to buy Rofin-Sinar Technologies Inc in a deal valued at around $942 million.

  • [By Joseph Griffin]

    Hood River Capital Management LLC decreased its position in shares of Coherent, Inc. (NASDAQ:COHR) by 63.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 69,773 shares of the scientific and technical instruments company’s stock after selling 122,518 shares during the quarter. Hood River Capital Management LLC owned about 0.28% of Coherent worth $13,075,000 as of its most recent SEC filing.

Hot Medical Stocks To Buy For 2019: American Tower Corporation (REIT)(AMT)

Advisors’ Opinion:

  • [By Andy Pai]

    American Tower Corp (NYSE: AMT), a real estate investment trust that owns cell phone towers, has also been one of Akre's most successful investments. Akre has owned shares in the company on and off since 2003. Akre believes American Tower is the ‘bottleneck business' within the wireless telecom industry. Regardless of advances in technology within the industry, network operators are reliant on the towers, giving the owners of cell phone towers the only effective monopoly in the industry.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on American Tower (AMT)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Anders Bylund, Tyler Crowe, and Demitrios Kalogeropoulos]

    If you’re looking for new ideas in that second category, you’re in luck. We asked a few of your fellow investors here at The Motley Fool to share their best stock ideas for the long haul. Read on to see how they came up with Nike(NYSE:NKE),Cintas(NASDAQ:CTAS), andAmerican Tower(NYSE:AMT).

Hot Medical Stocks To Buy For 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Leave a Reply

Your email address will not be published. Required fields are marked *